| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44e0905262f429c7590b40df8448c0c5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 |
| filingDate |
1999-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11ebc3b1d1c49338d9fe3403a36a9aca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5bef8d5350f78b57ac6557b086d6a92 |
| publicationDate |
2001-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-19957341-A1 |
| titleOfInvention |
Combination preparation containing a thalidomide compound and a phosphodiesterase type IV inhibitor |
| abstract |
Drugs are described in particular for the treatment of inflammatory and autoimmune diseases, which contain a combination of a thalidomide compound with a phosphodiesterase type IV inhibitor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2505200-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1578366-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1578366-A2 |
| priorityDate |
1999-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |